This review is an extensive summary of a recent event in Sydney on Hodgkin lymphoma. Attendees shared opinions and debated provocative findings from recent clinical trial updates that are challenging the management of HL.
The discussion was led by a panel including Professor Peter Borchmann, Dr Anita Shetty, Professor Mark Hertzberg, Dr Julie Crawford, and Dr Greg Hapgood.
Please login below to download this issue (PDF)